Document is current
Any future updates will be listed below
-
Authors
Tsujii, Yoshiki
Hayashi, Yoshito
Ishihara, Ryu
Yamaguchi, Shinjiro
Yamamoto, Masashi
Inoue, Takuya
Nagai, Kengo
Ogiyama, Hideharu
Yamada, Takuya
Nakahara, Masanori
Kizu, Takashi
Kanesaka, Takashi
Matsuura, Noriko
Ohta, Takashi
Nakamatsu, Dai
Yoshii, Shunsuke
Shinzaki, Shinichiro
Nishida, Tsutomu
Iijima, Hideki
Takehara, Tetsuo
- License Information
-
More Information
Article History
Received: 11 July 2022
Accepted: 27 November 2022
First Online: 19 December 2022
Declarations
:
: Ryu Ishihara has received honoraria for his lectures from Olympus, Daiichi-Sankyo, EA Pharma, Ono Pharmaceutical, AstraZeneca, and FUJIFILM, and other financial support from FUJIFILM and MSD. Takashi Kanesaka received grants from Yasuda Medical Foundation and honoraria for lectures from Olympus. Takashi Ohta received honoraria for his lectures from Bristol-Myers Squibb Japan, Chugai Pharmaceutical, Teijin Pharmaceutical, Takeda Pharmaceutical, Taiho Pharmaceutical and Eisai. Yoshiki Tsujii, Yoshito Hayashi, Shinjiro Yamaguchi, Masashi Yamamoto, Takuya Inoue, Kengo Nagai, Hideharu Ogiyama, Takuya Yamada, Masanori Nakahara, Takashi Kizu, Noriko Matsuura, Dai Nakamatsu, Shunsuke Yoshii, Shinichiro Shinzaki, Tsutomu Nishida, Hideki Iijima, and Tetsuo Takehara declare that they have no conflict of interest or financial ties to disclose.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and the Helsinki Declaration of 1964 and later versions. Written informed consent for inclusion in this study was obtained from all patients.
